Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
ACTG and Shionogi Announce Progress on Global Phase 3 Trial of Novel COVID-19 Oral Antiviral Agent S‑217622
Thursday, March 17, 2022The AIDS Clinical Trials Group ACTG the largest global HIV research network that expanded its focus to include evaluating outpatient treatments for COVID and Shionogi Co Ltd a global pharmaceutical company headquartered in Osaka Japan with a longsta...
AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19
Wednesday, March 16, 2022AbbVie and Scripps Research an independent nonprofit biomedical research and drug discovery institute today announced a global collaboration to develop potential novel directacting antiviral treatments for COVID Constant change is something weve expe...
Qualigen Therapeutics Extends Research Agreement with University of Louisville Research Foundation on RAS Program
Wednesday, March 16, 2022Qualigen Therapeutics Inc a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug designation while also commercializing diagnostics today announces the mutual extension of a...
Thermo Fisher Scientific to Expand Clinical Research Labs’ Capacity in Virginia
Tuesday, March 15, 2022Thermo Fisher Scientific Inc the world leader in serving science today announced it will invest million to expand its clinical research operations in Richmond Virginia The facilities which include laboratory operations acquired with the purchase of...
Element Biosciences Launches the AVITI™ System to Democratize Access to Genomics
Tuesday, March 15, 2022Element Biosciences Inc developer of a new and disruptive DNA sequencing platform today announced the commercial launch of the Element AVITI System a benchtop sequencer offering an unrivaled combination of performance cost and flexibility Elements pr...
Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform
Monday, March 14, 2022Ginkgo Bioworks the leading horizontal platform for cell programming today announced the entry into a definitive agreement to acquire FGen AG FGen a Swiss company specializing in strain development and optimization FGen has developed an ultrahighthro...
Cerveau Technologies Inc. Signs Agreement with Roche to Provide Novel Tau Imaging Biomarker for Disease Modifier Research
Friday, March 11, 2022Cerveau Technologies Inc today announced a research collaboration agreement with Roche Products Limited Roche on the use of Cerveaus FMK an investigational imaging agent in Positron Emission Tomography PET scans to assess the status and progression o...
Oragenics Engages KBI Biopharma to Support Development of Intranasal COVID-19 Vaccine Candidate NT-CoV2-1
Friday, March 11, 2022Oragenics Inc announced it has entered into an agreement with KBI Biopharma Inc KBI for the process transfer process optimization and cGMP manufacturing of the Companys intranasal vaccine candidate NTCoV which is expressed in a proprietary CHO cell l...
Twist Bioscience and Kriya Sign Agreement to Discover Novel Antibodies for Applications in Oncology Using Gene Therapy
Thursday, March 10, 2022Twist Bioscience Corporation a company enabling customers to succeed through its offering of highquality synthetic DNA using its silicon platform and Kriya Therapeutics Inc a fully integrated company pioneering novel technologies and therapeutics in...
BriOri BioTech Inc. Granted Patent for Topical Formulation of Vioxx
Thursday, March 10, 2022BriOri BioTech an emerging preclinical stage biotech company focused on developing a pipeline of opiatefree topical pain medications announces its patent for Topical Compositions Containing Rofecoxib Vioxx and Methods of Making and Using the Same was...
